North America Virology Specimen Collection Market By Sample, By Product Type, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

The North America Virology Specimen Collection Market is expected to witness market growth of 0.02% CAGR during the forecast period (2021-2027).

The global incidence of bacterial and viral diseases is on the rise. Climate change and the lowered immunity of a population, that is more protected from acquiring natural immunity can be responsible for this scenario. Globalization exacerbates the situation, as microbes which are native to one place mix with humans in other parts of the world.

To avoid contamination from ambient microorganisms, the assembling of Specimen is done with extreme caution and in a sterile atmosphere. To maintain hygiene standards, the equipment utilized must be of excellent quality. Following the COVID-19 outbreak, an inclusive mandate for sample testing was triggered, allowing developed and developing countries to contribute equally to global health bodies like the WHO (World Health Organization).

Under a USD 6.0 million contract with Inflammatix Inc., the US HHS supported the development of host-response testing technology as of November 2019. The company is working on three diagnostic tests that will determine if an illness is bacterial or viral in a matter of minutes. This enables clinicians to make informed, early treatment decisions. Such initiatives are also at the heart of the corporations' plan to increase the number of early diagnoses.

The US market dominated the North America Virology Specimen Collection Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $1,516.2 million by 2027. The Canada market is expected to witness a CAGR of 2.3% during (2021 - 2027). Additionally, The Mexico market is expected to showcase a CAGR of 1.4% during (2021 - 2027).

Based on Sample, the market is segmented into Nasopharyngeal Samples, Throat Samples, Cervical Samples, Nasal Samples, Blood Samples, Oral Samples, and Others. Based on Product Type, the market is segmented into Viral Transport Media, Specimen Collection Tubes, Blood Collection Kits and Swabs. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trinity Biotech Plc, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, DiaSorin S.p.A., Vircell S.L., Quidel Corporation, Titan Biotech Ltd., Puritan Medical Products, Copan Italia s.p.a., and Hardy Diagnostics.

Scope of the Study

Market Segments Covered in the Report:

By Sample

• Nasopharyngeal Samples
• Throat Samples
• Cervical Samples
• Nasal Samples
• Blood Samples
• Oral Samples, and
• Others

By Product Type

• Viral Transport Media
• Specimen Collection Tubes
• Blood Collection Kits and
• Swabs

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Trinity Biotech Plc
• Thermo Fisher Scientific, Inc.
• Becton, Dickinson and Company
• DiaSorin S.p.A.
• Vircell S.L.
• Quidel Corporation
• Titan Biotech Ltd.
• Puritan Medical Products
• Copan Italia s.p.a.
• Hardy Diagnostics

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free